COVID-19 pandemic impacted care of patients with cystic fibrosis in US

While in-person visits for patients with cystic fibrosis decreased from 2019 to 2020 during the COVID-19 pandemic, a new study found no evidence of worse lung disease, nutrition or increased risk for pulmonary exacerbations.
“The CF Foundation recommends frequent clinical encounters to monitor for progression of lung disease, surveillance of respiratory microbiology and monitoring for cystic fibrosis-related complications. During the spring [2020] peak of the pandemic, this monitoring was disrupted. The impact of changes in care for people with cystic fibrosis may not be known for some time,”

While in-person visits for patients with cystic fibrosis decreased from 2019 to 2020 during the COVID-19 pandemic, a new study found no evidence of worse lung disease, nutrition or increased risk for pulmonary exacerbations.
“The CF Foundation recommends frequent clinical encounters to monitor for progression of lung disease, surveillance of respiratory microbiology and monitoring for cystic fibrosis-related complications. During the spring [2020] peak of the pandemic, this monitoring was disrupted. The impact of changes in care for people with cystic fibrosis may not be known for some time,”